Skip to main content

Advertisement

SpringerLink
Log in

Pain Management in Osteoporosis

  • Review Article
  • Published:
Indian Journal of Orthopaedics Aims and scope Submit manuscript

Abstract

The most prevalent metabolic bone disease, osteoporosis, is characterized by a decrease in bone mineral density and alterations to the bone's microstructure, both of which can result in fragility fractures. It affects a significant section of the population. Acute or chronic pain from these fractures is typical in elderly adults with other coexisting conditions. Since the antiresorptive medication only partially reduces pain, other analgesics are required for effective pain management. NSAIDs or selective COX-2 inhibitors can reduce acute pain, but persistent neuropathic pain is difficult to manage with these drugs. Opioids have their adverse effects and safety concerns, although they can be used to address acute or chronic pain. Hence, a multifaceted approach is to be implemented, including pharmacological and nonpharmacological therapy and surgical treatment in a selected number of cases. This chapter briefly describes the etiology of pain, its mechanism, and pain management in osteoporotic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Availability of Data and Materials

No repositories were used for data.

References

  1. Kanis, J. A., McCloskey, E. V., Johansson, H., Oden, A., Melton, L. J., 3rd., & Khaltaev, N. (2008). A reference standard for the description of osteoporosis. Bone, 42(3), 467–475.

    Article  CAS  PubMed  Google Scholar 

  2. Sozen, T., Ozisik, L., & Basaran, N. C. (2017). An overview and management of osteoporosis. European Journal of Rheumatology, 4(1), 46–56.

    Article  PubMed  Google Scholar 

  3. Tarantino, U., Capone, A., Planta, M., D’Arienzo, M., Letizia Mauro, G., Impagliazzo, A., et al. (2010). The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: Results from a 3-year multicenter study. Arthritis Research & Therapy, 12(6), R226.

    Article  Google Scholar 

  4. O’Neill, T. W., Felsenberg, D., Varlow, J., Cooper, C., Kanis, J. A., & Silman, A. J. (1996). The prevalence of vertebral deformity in european men and women: The European Vertebral Osteoporosis Study. Journal of Bone and Mineral Research, 11(7), 1010–1018.

    Article  PubMed  Google Scholar 

  5. Tarantino, U., Baldi, J., Celi, M., Rao, C., Liuni, F. M., Iundusi, R., & Gasbarra, E. (2013). Osteoporosis and sarcopenia: The connections. Aging Clinical and Experimental Research, 25(Suppl 1), S93–S95.

    Article  PubMed  Google Scholar 

  6. Sinaki, M., Brey, R. H., Hughes, C. A., Larson, D. R., & Kaufman, K. R. (2005). Balance disorder and increased risk of falls in osteoporosis and kyphosis: Significance of kyphotic posture and muscle strength. Osteoporosis International, 16(8), 1004–1010.

    Article  PubMed  Google Scholar 

  7. Kim, D. H., & Vaccaro, A. R. (2006). Osteoporotic compression fractures of the spine; current options and considerations for treatment. Spine Journal, 6(5), 479–487.

    Article  Google Scholar 

  8. Iolascon, G., Gimigliano, F., Malavolta, N., Tarantino, U., Fornari, R., Greco, E., et al. (2012). Effectiveness of teriparatide treatment on back pain-related functional limitations in individuals affected by severe osteoporosis: A prospective pilot study. Clinical Cases in Mineral and Bone Metabolism, 9(3), 161–165.

    PubMed  PubMed Central  Google Scholar 

  9. Nagae, M., Hiraga, T., Wakabayashi, H., Wang, L., Iwata, K., & Yoneda, T. (2006). Osteoclasts play a part in pain due to the inflammation adjacent to bone. Bone, 39(5), 1107–1115.

    Article  CAS  PubMed  Google Scholar 

  10. Howe, T. E., Shea, B., Dawson, L. J., et al. (2011). Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database of Systematic Reviews, 7, CD000333.

    Google Scholar 

  11. Davidovitch, Z., Nicolay, O., Ngan, P. W., & Shanfeld, J. L. (1988). Neurotransmitters cytochines, and die control of alveolar bone remodeling in orthodontìcs. Dental Clinics of North America, 32, 411–435.

    Article  CAS  PubMed  Google Scholar 

  12. Bjurholm, A., Kreicbergs, A., Terenius, L., Goldstein, M., & Schultzberg, M. (1988). Neuropeptide Y tyrosine hydroxylase and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues. Journal of the Autonomic Nervous System, 25(2–3), 119–125.

    Article  CAS  PubMed  Google Scholar 

  13. Jimenez-Andrade, J. M., Mantyh, W. G., Bloom, A. P., Freeman, K. T., Ghilardi, J. R., Kuskowski, M. A., & Mantyh, P. W. (2010). The effect of aging on the density of the sensory nerve fiber innervation of bone and acute skeletal pain. Neurobiology of Aging, 33, 921–932.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Zylka, M. J., & Rice, F. L. (2005). Anderson DJ Topographically distinct epidermal nociceptive circuits revealed by axonal tracers targeted to Mrgprd. Neuron, 45, 17–25.

    Article  CAS  PubMed  Google Scholar 

  15. Bataille, C., Mauprivez, C., Hay, E., Baroukh, B., Brun, A., Chaussain, C., Marie, P. J., Saffar, J. L., & Cherruau, M. (2012). Different sympathetic pathways control the metabolism of distinct bone envelopes. Bone, 50, 1162–1172.

    Article  CAS  PubMed  Google Scholar 

  16. Eimar, H., Tamimi, I., Murshed, M., & Tamimi, F. (2013). Cholinergic regulation of bone. Journal of Musculoskeletal and Neuronal Interactions, 13, 124–132.

    CAS  PubMed  Google Scholar 

  17. He, J. Y., Jiang, L. S., & Dai, L. Y. (2011). The roles of the sympathetic nervous system in osteoporotic diseases: A review of experimental and clinical studies. Ageing Research Reviews, 10, 253–263.

    Article  CAS  PubMed  Google Scholar 

  18. Julius, D., & Basbaum, A. I. (2001). Molecular mechanisms of nociception. Nature, 413(6852), 203–210.

    Article  CAS  PubMed  Google Scholar 

  19. Lerner, U. H., & Persson, E. (2008). Osteotropic effects by the neuropeptides calcitonin gene-related peptide, substance P and vasoactive intestinal peptide. Journal of Musculoskeletal and Neuronal Interactions, 8(2), 154–165.

    CAS  PubMed  Google Scholar 

  20. Abdelaziz, D. M., Abdullah, S., Magnussen, C., Ribeiro-da-Silva, A., Komarova, S. V., Rauch, F., & Stone, L. S. (2015). Behavioral signs of pain and functional impairment in a mouse model of osteogenesis imperfecta. Bone, 81, 400–406.

    Article  PubMed  Google Scholar 

  21. Eide, P. K. (2000). Wind-up and the NMDA receptor complex from a clinical perspective. European Journal of Pain, 4(1), 5–15.

    Article  CAS  PubMed  Google Scholar 

  22. Lange, U., Teichmann, J., & Uhlemann, C. (2005). Current knowledge about physiotherapeutic strategies in osteoporosis prevention and treatment. Rheumatology International, 26(2), 99–106.

    Article  CAS  PubMed  Google Scholar 

  23. Angın, E., Erden, Z., & Can, F. (2015). The effects of clinical pilates exercises on bone mineral density (BMD), physical performance and quality of life of women with postmenopausal osteoporosis. Journal of Back and Musculoskeletal Rehabilitation, 28(4), 849–858.

    Article  PubMed  Google Scholar 

  24. Bautmans, I., Van Arken, J., Van Mackelenberg, M., & Mets, T. (2010). Rehabilitation using manual mobilization for thoracic kyphosis in elderly postmenopausal patients with osteoporosis. Journal of Rehabilitation Medicine, 42(2), 129–135.

    Article  PubMed  Google Scholar 

  25. Benedetti, M. G., Furlini, G., Zati, A., & Letizia, M. G. (2018). The effectiveness of physical exercise on bone density in osteoporotic patients. BioMed Research International, 2018, 4840531.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Gregg, E. W., Cauley, J. A., Seeley, D. G., Ensrud, K. E., & Bauer, D. C. (1998). Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group. Annals of Internal Medicine, 129(2), 81–88.

    Article  CAS  PubMed  Google Scholar 

  27. Lee, C. H., Lee, T. Y., Her, J. S., Liao, W. L., & Hsieh, C. L. (2015). Single-blinded, randomized preliminary study evaluating the effect of transcutaneous electrical nerve stimulation on postoperative pain in patients with Colles’ fracture. Journal of Alternative and Complementary Medicine, 21(12), 754–758.

    Article  PubMed  Google Scholar 

  28. Schiller, J., Korallus, C., Bethge, M., Karst, M., Schmalhofer, M. L., Gutenbrunner, C., & Fink, M. G. (2016). Effects of acupuncture on quality of life and pain in patients with osteoporosis—A pilot randomized controlled trial. Archives of Osteoporosis, 11(1), 34.

    Article  PubMed  Google Scholar 

  29. Mert, T., Kurt, A. H., Altun, I., Celik, A., Baran, F., & Gunay, I. (2017). Pulsed magnetic field enhances therapeutic efficiency of mesenchymal stem cells in chronic neuropathic pain model. Bioelectromagnetics, 38(4), 255–264.

    Article  CAS  PubMed  Google Scholar 

  30. Bistolfi, F. (2007). Extremely low-frequency pulsed magnetic fields and multiple sclerosis: Effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis. Neuroradiology Journal, 20(6), 676–693.

    Article  CAS  PubMed  Google Scholar 

  31. Maestu, C., Blanco, M., Nevado, A., Romero, J., Rodrguez-Rubio, P., Galindo, J., et al. (2013). Reduction of pain thresholds in fibromyalgia after very low-intensity magnetic stimulation: A double-blinded, randomized placebo-controlled clinical trial. Pain Research Management, 18, e101–e106.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Iwamoto, J., Takeda, T., Sato, Y., & Uzawa, M. (2005). Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate. Aging Clinical and Experimental Research, 17(2), 157–163.

    Article  CAS  PubMed  Google Scholar 

  33. Ehde, D. M., Dillworth, T. M., & Turner, J. A. (2014). Cognitive-behavioral therapy for individuals with chronic pain: Efficacy, innovations, and directions for research. American Psychologist, 69(2), 153–166.

    Article  PubMed  Google Scholar 

  34. Yang, J., Bauer, B. A., Wahner-Roedler, D. L., Chon, T. Y., & Xiao, L. (2020). The modified WHO analgesic ladder: Is it appropriate for chronic non-cancer pain? Journal of Pain Research, 13, 411–417.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R., & Reginster, J. Y. (2013). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International, 24(1), 23–57.

    Article  CAS  PubMed  Google Scholar 

  36. Wells, G., Cranney, A., Shea, B., & Tugwell, P. (1997). Responsiveness of endpoints in osteoporosis clinical trials. Journal of Rheumatology, 24, 1230–1233.

    CAS  PubMed  Google Scholar 

  37. Bannuru, R. R. D. U., & McAlindon, T. E. (2010). Reassessing the role of acetaminophen in osteoarthritis: systematic review and meta-analysis. Osteoarthritis Research Society International World Congress; 2010 Sep 23–26; Brussels, Belgium. Osteoarthritis Cartilage, 18(Suppl 2), S250.

    Article  Google Scholar 

  38. Coxib and traditional NSAID Trialists’ (CNT) Collaboration, Bhala, N., Emberson, J., Merhi, A., et al. (2013). Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: metaanalyses of individual participant data from randomised trials. Lancet, 382(9894), 769–779.

    Article  Google Scholar 

  39. Kress, H. G., Baltov, A., Basiński, A., Berghea, F., Castellsague, J., Codreanu, C., et al. (2016). Acute pain: A multifaceted challenge-the role of nimesulide. Current Medical Research and Opinion, 32(1), 23–36.

    Article  CAS  PubMed  Google Scholar 

  40. Labianca, R., Sarzi-Puttini, P., Zuccaro, S. M., Cherubino, P., Vellucci, R., & Fornasari, D. (2012). Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain. Clinical Drug Investigation, 32(Suppl 1), 53–63.

    Article  CAS  PubMed  Google Scholar 

  41. Oral, A., Küçükdeveci, A. A., Varela, E., Ilieva, E. M., Valero, R., Berteanu, M., & Christodoulou, N. (2013). Osteoporosis. The role of physical and rehabilitation medicine physicians. The European perspective based on the best evidence. A paper by the UEMS-PRM Section Professional Practice Committee. European Journal of Physical and Rehabilitation Medicine, 49(4), 565–577.

    CAS  PubMed  Google Scholar 

  42. Hou, Y. C., Wu, C. C., Liao, M. T., Shyu, J. F., Hung, C. F., Yen, T. H., Lu, C. L., & Lu, K. C. (2018). Role of nutritional vitamin D in osteoporosis treatment. Clinica Chimica Acta, 484, 179–191.

    Article  CAS  Google Scholar 

  43. Deardorff, W. J., Cenzer, I., Nguyen, B., & Lee, S. J. (2022). Time to benefit of bisphosphonate therapy for the prevention of fractures among postmenopausal women with osteoporosis: A meta-analysis of randomized clinical trials. JAMA Internal Medicine, 182(1), 33–41.

    Article  CAS  PubMed  Google Scholar 

  44. Iwamoto, J., Makita, K., Sato, Y., Takeda, T., & Matsumoto, H. (2011). Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis. Osteoporosis International, 22(10), 2735–2742.

    Article  CAS  PubMed  Google Scholar 

  45. Ohtori, S., Akazawa, T., Murata, Y., Kinoshita, T., Yamashita, M., Nakagawa, K., et al. (2010). Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures. Journal of Clinical Neuroscience, 17(2), 209–213.

    Article  CAS  PubMed  Google Scholar 

  46. Dursun, N., Dursun, E., & Yalçin, S. (2001). Comparison of alendronate, calcitonin and calcium treatments in postmenopausal osteoporosis. International Journal of Clinical Practice, 55(8), 505–509.

    Article  CAS  PubMed  Google Scholar 

  47. Vujasinović-Stupar, N., Milić, N., Petrović-Rackov, L., Prodanović, N., Mijailović-Ivković, M., Grujić, Z., et al. (2010). ESTHER Study Group Efficacy and safety of once monthly ibandronate treatment in patients with reduced bone mineral density—ESTHER study. Srpski Arhiv za Celokupno Lekarstvo, 138(1–2), 56–61.

    Article  PubMed  Google Scholar 

  48. Koivisto, K., Kyllönen, E., Haapea, M., Niinimäki, J., Sundqvist, K., Pehkonen, T., et al. (2014). Efficacy of zoledronic acid for chronic low back pain associated with modic changes in magnetic resonance imaging. BMC Musculoskeletal Disorders, 15, 64.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Cummings, S. R., San Martin, J., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., Kutilek, S., Adami, S., Zanchetta, J., Libanati, C., Siddhanti, S., & Christiansen, C. (2009). FREEDOM trial denosumab for prevention of fractures in postmenopausal women with osteoporosis. New England Journal of Medicine, 361, 756–765.

    Article  CAS  PubMed  Google Scholar 

  50. Cleeland, C. S., Body, J. J., Stopeck, A., von Moos, R., Fallowfield, L., Mathias, S. D., et al. (2013). Pain outcomes in patients with advanced breast cancer and bone metastases: Results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer, 119, 832–838.

    Article  CAS  PubMed  Google Scholar 

  51. Petranova, T., Sheytanov, I., Monov, S., Nestorova, R., & Rashkov, R. (2014). Denosumab improves bone mineral density and microarchitecture and reduces bone pain in women with osteoporosis with and without glucocorticoid treatment. Biotechnology and Biotechnological Equipment, 28(6), 1127–1137.

    Article  PubMed  Google Scholar 

  52. Nevitt, M. C., Chen, P., Dore, R. K., Reginster, J. Y., Kiel, D. P., Zanchetta, J. R., Glass, E. V., & Krege, J. H. (2006). Reduced risk of back pain following teriparatide treatment: A meta-analysis. Osteoporosis International, 17, 273–280.

    Article  PubMed  Google Scholar 

  53. Miller, P. D., Delmas, P. D., Lindsay, R., Watts, N. B., Luckey, M., Adachi, J., et al. (2008). Open-label study to determine how prior therapy with alendronate or risedronate in postmenopausal women with osteoporosis influences the clinical effectiveness of teriparatide investigators early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. The Journal of Clinical Endocrinology and Metabolism, 93, 3785–3793.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Manuele, S., Sorbello, L., Puglisi, N., Grasso, S., La Malfa, L., D’Urbino, G., et al. (2007). The teriparatide in the treatment of severe senile osteoporosis. Archives of Gerontology and Geriatrics, 44(Suppl 1), 249–258.

    Article  CAS  PubMed  Google Scholar 

  55. Tanna, N. K., & Ong, T. (2022). Pharmacological options for pain control in patients with vertebral fragility fractures. Osteoporosis and Sarcopenia, 8(3), 93–97.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Boucher, E., Rosgen, B., & Lang, E. (2020). Efficacy of calcitonin for treating acute pain associated with osteoporotic vertebral compression fracture: An updated systematic review. CJEM, 22, 359–367.

    Article  PubMed  Google Scholar 

  57. Knopp, J. A., Diner, B. M., Blitz, M., Lyritis, G. P., & Rowe, B. H. (2015). Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: A systematic review of randomized, controlled trials. Osteoporosis International, 16, 1281–1290.

    Article  Google Scholar 

  58. Knopp-Sihota, J. A., Newburn-Cook, C. V., Homik, J., Cummings, G. G., & Voaklander, D. (2012). Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: A systematic review and meta-analysis. Osteoporosis International, 2012(23), 17–38.

    Article  Google Scholar 

  59. Endo, N., Fujino, K., Doi, T., Akai, M., Hoshino, Y., Nakano, T., & Iwaya, T. (2017). Effect of elcatonin versus nonsteroidal anti-inflammatory medications for acute back pain in patients with osteoporotic vertebral fracture: A multiclinic randomized controlled trial. Journal of Bone and Mineral Metabolism, 35, 375–384.

    Article  CAS  PubMed  Google Scholar 

  60. Knopp-Sihota, J. A., Newburn-Cook, C. V., Homik, J., Cummings, G. G., & Voaklander, D. (2012). Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: A systematic review and meta-analysis. Osteoporosis International, 23, 17–38.

    Article  CAS  PubMed  Google Scholar 

  61. Kaufman, J. M., Audran, M., Bianchi, G., Braga, V., Diaz-Curiel, M., Francis, R. M., Goemaere, S., Josse, R., Palacios, S., Ringe, J. D., Felsenberg, D., & Boonen, S. (2013). Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. Journal of Clinical Endocrinology and Metabolism, 98(2), 592–601.

    Article  CAS  PubMed  Google Scholar 

  62. Negri, A. L., & Spivacow, F. R. (2012). Healing of subtrochanteric atypical fractures after strontium ranelate treatment. Clinical Cases in Mineral and Bone Metabolism, 9(3), 166–169.

    PubMed  PubMed Central  Google Scholar 

  63. Cianferotti, L., D’Asta, F., & Brandi, M. L. (2013). A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis. Therapeutic Advances in Musculoskeletal Disease, 5(3), 127–139.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Silverman, S. L., Christiansen, C., Genant, H. K., Vukicevic, S., Zanchetta, J. R., de Villiers, T. J., et al. (2008). Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: Results from a 3-year, randomized, placebo-, and active-controlled clinical trial. Journal of Bone and Mineral Research, 23, 1923–1934.

    Article  CAS  PubMed  Google Scholar 

  65. Scharla, S., Oertel, H., Helsberg, K., Kessler, F., Langer, F., & Nickelsen, T. (2006). Skeletal pain in postmenopausal women with osteoporosis: Prevalence and course during raloxifene treatment in a prospective observational study of 6 months duration. Current Medical Research and Opinion, 22, 2393–2402.

    Article  CAS  PubMed  Google Scholar 

  66. Macías-Hernández, S. I., Chávez-Arias, D. D., Miranda-Duarte, A., Coronado-Zarco, R., & Diez-García, M. P. (2015). Percutaneous vertebroplasty versus conservative treatment and rehabilitation in women with vertebral fractures due to osteoporosis: A prospective comparative study. Revista de Investigacion Clinica, 67(2), 98–103.

    PubMed  Google Scholar 

  67. Sanli, I., van Kuijk, S. M. J., de Bie, R. A., van Rhijn, L. W., & Willems, P. C. (2020). Percutaneous cement augmentation in the treatment of osteoporotic vertebral fractures (OVFs) in the elderly: A systematic review. European Spine Journal, 29(7), 1553–1572.

    Article  CAS  PubMed  Google Scholar 

  68. Mears, S. C. (2013). Management of severe osteoporosis in primary total hip arthroplasty. Current Translational Geriatrics and Experimental Gerontology Reports, 2, 99–104.

    Article  Google Scholar 

  69. Karachalios, T. S., Koutalos, A. A., & Komnos, G. A. (2020). Total hip arthroplasty in patients with osteoporosis. HIP International, 30(4), 370–379.

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Department of Orthopaedics, All India Institute of Medical Sciences, India, Jodhpur

    Rajesh Kumar Rajnish & Abhay Elhence

  2. Harishchandra Institute of Orthopedics & Research, Patna, India

    S. S. Jha

  3. Department of Orthopaedics, Ganga Hospital, 313, Mettupalayam Road, Coimbatore, 641 043, India

    Palanisami Dhanasekararaja

Authors
  1. Rajesh Kumar Rajnish
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abhay Elhence
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. S. Jha
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Palanisami Dhanasekararaja
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All the above-mentioned authors have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.

Corresponding author

Correspondence to Rajesh Kumar Rajnish.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Ethical Approval

Not applicable.

Informed Consent

For this type of study informed consent is not required.

Consent to Participate

Not applicable.

Consent to Publish

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rajnish, R.K., Elhence, A., Jha, S.S. et al. Pain Management in Osteoporosis. JOIO 57 (Suppl 1), 230–236 (2023). https://doi.org/10.1007/s43465-023-01047-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43465-023-01047-6

Keywords

Search

Navigation